Fig. 4
From: NHERF1 and tumor microenvironment: a new scene in invasive breast carcinoma
Survival analyses. a Disease-free-survival (DFS) curves for patients with nTWIST1+ versus nTWIST1- expression (p < 0.001). b DFS curves for patients with simultaneously nTWIST1-/mNHERF1+ expression respect to patients with nTWIST1+/mNHERF1- expression (p < 0.001). c DFS curves for patients with simultaneously nTWIST1-/mNHERF1- expression respect to patients with nTWIST1+/mNHERF1+ expression (p = 0.510). d DFS curves for patients with simultaneously nTWIST1-/cNHERF1- expression respect to patients with nTWIST1+/cNHERF1+ expression (p = 0.004). e DFS curves for patients with simultaneously nTWIST1-/cNHERF1+ expression respect to patients with nTWIST1+/cNHERF1- expression (p = 0.037). f DFS curves for patients with simultaneously cVEGF-/cNHERF1- expression respect to patients with cVEGF+/cNHERF1+ expression (p = 0.430). g DFS curves for patients with simultaneously cVEGFR1-/cNHERF1- expression respect to patients with cVEGFR1+/cNHERF1+ expression (p = 0.180). h DFS curves for patients with simultaneously nHIF-1α-/cNHERF1+ expression respect to patients with nHIF-1α+/cNHERF1- expression (p = 0.950)